{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:34:35Z","timestamp":1781548475247,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.autrev.2009.04.006","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T09:19:36Z","timestamp":1241774376000},"page":"140-143","source":"Crossref","is-referenced-by-count":148,"title":["Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis"],"prefix":"10.1016","volume":"9","author":[{"given":"P\u00e9ter","family":"Szodoray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Kapit\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Gyetvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Lakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","article-title":"Understanding the genetic contribution to rheumatoid arthritis","volume":"17","author":"van der Helm-van Mil","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2009.04.006_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.berh.2006.05.005","article-title":"Treating very early rheumatoid arthritis","volume":"20","author":"Raza","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/BOR.0b013e3282fbd22a","article-title":"Antibodies to citrullinated proteins in arthritis: pathology and promise","volume":"20","author":"Klareskog","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2009.04.006_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1196\/annals.1422.034","article-title":"Citrullination by peptidylarginine deiminase in rheumatoid arthritis","volume":"1108","author":"Suzuki","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.autrev.2009.04.006_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2009.04.006_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2004.07.004","article-title":"Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis","volume":"71","author":"Sebbag","year":"2004","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.autrev.2009.04.006_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","article-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies,\u201d autoantibodies specific for rheumatoid arthritis","volume":"92","author":"Simon","year":"1993","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib10","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis","volume":"34","author":"Soos","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2009.04.006_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","article-title":"Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids","volume":"65","author":"Takizawa","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2009.04.006_bib13","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2009.04.006_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib15","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2009.04.006_bib16","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2009.04.006_bib18","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.04.006_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","article-title":"Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis","volume":"1143","author":"van Venrooij","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.autrev.2009.04.006_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar1836","article-title":"Does a positive anti-CCP test identify a distinct arthritis entity?","volume":"7","author":"Skogh","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2009.04.006_bib21","first-page":"689","article-title":"The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis","volume":"17","author":"van Jaarsveld","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib22","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2009.04.006_bib23","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/ar1896","article-title":"Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis","volume":"8","author":"Meyer","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2009.04.006_bib24","article-title":"Autoantibody profiling in patients with very early rheumatoid arthritis \u2014 a follow-up study","author":"Nell-Duxneuner","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2009.04.006_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","article-title":"High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study","volume":"67","author":"Syversen","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2009.04.006_bib26","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/art.22868","article-title":"The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register","volume":"56","author":"Bukhari","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2009.04.006_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17402520500233510","article-title":"The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis","volume":"12","author":"Shovman","year":"2005","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2009.04.006_bib28","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2009.04.006_bib29","first-page":"32","article-title":"Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis","volume":"10","author":"Kapitany","year":"2008","journal-title":"Isr Med Assoc J"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/ken192","article-title":"Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis","volume":"47","author":"Goeb","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2009.04.006_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2005.09.005","article-title":"Redefining the HLA and RA association: to be or not to be anti-CCP positive","volume":"25","author":"de Vries","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.04.006_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1423.004","article-title":"Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis","volume":"1110","author":"Poor","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2009.04.006_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.22373","article-title":"The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2009.04.006_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.24135","article-title":"Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region","volume":"60","author":"Ding","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2009.04.006_bib35","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","article-title":"Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles","volume":"56","author":"Verpoort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.04.006_bib36","article-title":"Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects","author":"Farago","year":"2008","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.autrev.2009.04.006_bib37","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/rheumatology\/kem006","article-title":"Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients","volume":"46","author":"Feitsma","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2009.04.006_bib38","article-title":"The contribution of Fc gamma receptor IIIA gene 158V\/F polymorphism and copy number variation to the risk of ACPA positive rheumatoid arthritis","author":"Thabet","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2009.04.006_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","article-title":"Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis","volume":"2","author":"Klareskog","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2009.04.006_bib40","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.22597","article-title":"Strong combined gene\u2013environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case\u2013control study in Denmark","volume":"56","author":"Pedersen","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T02:26:21Z","timestamp":1545272781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1568997209001116"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.04.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}